We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.55B
AUM Growth
-$772M
Cap. Flow
-$469M
Cap. Flow %
-13.21%
Top 10 Hldgs %
58.31%
Holding
161
New
16
Increased
39
Reduced
56
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Industrials 21.06%
3 Consumer Discretionary 20.58%
4 Healthcare 13.81%
5 Materials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTRX icon
26
Quanterix
QTRX
$190M
$25.6M 0.72%
514,488
ICVX
27
DELISTED
Icosavax, Inc. Common Stock
ICVX
$23.3M 0.66%
+786,575
New +$26.7M
BTRS
28
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$21.6M 0.61%
+2,031,892
New +$23.5M
CNTG
29
DELISTED
Centogene N.V. Common Shares
CNTG
$21.2M 0.6%
1,923,085
+258,413
+16% +$2.79M
MLCO icon
30
Melco Resorts & Entertainment
MLCO
$2.14B
$21.2M 0.6%
2,066,285
-517,866
-20% -$6.81M
FDX icon
31
FedEx
FDX
$75.4B
$20.7M 0.58%
94,276
-33,003
-26% -$8.96M
ESPR
32
DELISTED
Esperion Therapeutics
ESPR
$20.6M 0.58%
1,713,176
SILV
33
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$19.6M 0.55%
2,804,448
-276,904
-9% -$2.19M
HCC icon
34
Warrior Met Coal
HCC
$4.86B
$18.5M 0.52%
795,295
-14,825
-2% -$300K
GTH
35
DELISTED
Genetron Holdings Limited ADS
GTH
$17.2M 0.49%
414,605
+143,047
+53% +$6.59M
RXRX icon
36
Recursion Pharmaceuticals
RXRX
$1.73B
$15.2M 0.43%
661,703
+189,151
+40% +$5.36M
TAL icon
37
TAL Education Group
TAL
$6.87B
$14.8M 0.42%
3,063,279
+1,765,962
+136% +$15.7M
NSTG
38
DELISTED
NanoString Technologies, Inc.
NSTG
$13.5M 0.38%
280,671
XYZ
39
Block Inc
XYZ
$47.5B
$12.8M 0.36%
+53,422
New +$13.7M
SUZ icon
40
Suzano
SUZ
$10.1B
$12.4M 0.35%
1,241,314
ULTA icon
41
Ulta Beauty
ULTA
$24.3B
$12M 0.34%
33,358
-135,692
-80% -$49M
RXDX
42
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$11.9M 0.34%
502,520
+147,619
+42% +$3.48M
PLNT icon
43
Planet Fitness
PLNT
$3.78B
$10.4M 0.29%
132,486
-66,814
-34% -$5.08M
EPZM
44
DELISTED
Epizyme, Inc
EPZM
$9.75M 0.27%
+1,903,893
New +$11.6M
PRDS
45
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.61M 0.27%
+965,950
New +$9.6M
OMGA
46
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$9.43M 0.27%
+500,000
New +$9.59M
CHRS icon
47
Coherus Oncology
CHRS
$196M
$9.25M 0.26%
575,510
COGT icon
48
Cogent Biosciences
COGT
$7.24B
$8.26M 0.23%
982,298
+156,179
+19% +$1.2M
FXLV
49
DELISTED
F45 Training Holdings Inc.
FXLV
$8.23M 0.23%
+550,000
New +$8.06M
MSFT icon
50
Microsoft
MSFT
$3.71T
$8.02M 0.23%
28,431
+3,433
+14% +$999K

Similar funds

Platinum Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Platinum Investment Management held 161 positions worth $3.55B, down 18% from $4.32B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management withdrew a net $469M in Q3 2021, closing 15 positions and reducing 56 holdings. Its most notable exit was Wabtec, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in Icosavax, Inc. Common Stock worth $23.3M.

  • Platinum Investment Management's largest Q3 2021 buy was Icosavax, Inc. Common Stock: 786,575 shares worth $23.3M.
  • Platinum Investment Management added most to Alibaba in Q3 2021, an estimated $126M increase.
  • Platinum Investment Management's biggest Q3 2021 reduction was Ally Financial, cutting an estimated $177M.
  • Platinum Investment Management fully exited Wabtec in Q3 2021, selling an estimated $106M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.55B portfolio in Q3 2021.
  • Platinum Investment Management opened 16 new positions and closed 15 in Q3 2021.
  • Platinum Investment Management's portfolio value fell 18% quarter-over-quarter to $3.55B.

Based on Platinum Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.